Mrinalini Dey DrMiniDey
4 years 10 months ago
Important to properly assess #sarcopenia in older patients with #RA. Useful tools include:
👉🏼SARC-F questionnaire (≥ 4 is abnormal)
👉🏼Muscle function tests incl Short Physical Performance Battery
#ACR21 @RheumNow https://t.co/9l6b7tJ1xC
Dr. Rachel Tate uptoTate
4 years 10 months ago
Retrospective French case study showed PAH is rare but potentially severe complication of AOSD. In this trial of 13, it only affected women. Further studies needed! Abs 1100 #ACR21 #RheumNow @RheumNow https://t.co/6CufqRV0Qg https://t.co/h73mxsJswi
Olga Petryna DrPetryna
4 years 10 months ago
Abst1094 #acr21 @RheumNow rheum pts and extremely ⬆️ESR: infection vs flare: Thrombocyte, MCV, albumin and total protein were significantly lower in infection group, however; neutrophil, MPV, CRP and ferritin were significantly lower in flare-up group https://t.co/C6MQo86Ljb
Pedro Castillo _Castillo_Pedro
4 years 10 months ago
Urinary CD163: Potential Biomarker in LN
💠Correlated w/histological activity
💠⬆️in prolif LN
💠⬇️in responders
💠Clinical features + biomarkers may provide non-invasive method to dx and monitor response in LN
https://t.co/u910ehQH74
#ACR2021 Abst#1422 @RheumNow #ACRBest
David Liew drdavidliew
4 years 10 months ago
TCZ in COVID-19: studies that form the basis of the EUA, direct from the @US_FDA
(now can we have enough for our RA, GCA, and JIA pts still on it, please @genentech @Roche?)
#ACR21 FDA update @RheumNow https://t.co/ZQv9XtoRJZ
TheDaoIndex KDAO2011
4 years 10 months ago
“Geriatrics is a team sport!” – Dr. Buehring #ACR11 @rheumnow @UnaMakris #GeriRheum #aging https://t.co/ckAJsi696Y
Md Yuzaiful Md Yusof Yuz6Yusof
4 years 10 months ago
#ACR21 #Abstr Are we close to not needing kidney biopsy to assess #lupus nephritis? A study showed Urinary CD163:
⬆️in proliferating LN
⬇️in responders with good AUC
Further works: ?marker for flare, how sensitive vs uPCR, different therapies
@RheumNow https://t.co/d0quh9wu5h https://t.co/zWm8SJvRXz
Dr. Rachel Tate uptoTate
4 years 10 months ago
Hip involvement/TJR assoc'd w/ MEFV+ vs HLA-B27+ in FMF/SpA pts vs SpA. FMF/SpA: more severe disease, worse outcomes, & destructive hip involvement vs SpA, particularly in pts with MEFV variants & M694V homozygosity. Abs 1108 #ACR21 #RheumNow @RheumNow https://t.co/hlnN26AYgE https://t.co/1jHeVxKs7O
Akhil Sood MD AkhilSoodMD
4 years 10 months ago
Very interesting talks by @UnaMakris and #DrBuhring on Multicomplexity in the Aging Patient with #RA
#ACR21 @RheumNow https://t.co/WA8YtEpKhk
Richard Conway RichardPAConway
4 years 10 months ago
Open label study of only 8 weeks of steroid with tocilizumab for 1 year in GCA. 74% sustained steroid free remission at 1 year. Wow! Needs an RCT. Abstr#1413 #ACR21 @RheumNow https://t.co/c82qGJCFip
TheDaoIndex KDAO2011
4 years 10 months ago
“NSAIDS are not off the table for older adults!” – Dr @unamakris says use⬇️dose &monitor; GFR may be misleading (toxicity seen w/normal Cr) She’s not a fan of tramadol, but recc topical pain meds, SSRI/NSRI, short-acting⬇️dose opioids when acet & nonpharm Rx fail @rheumnow #ACR21 https://t.co/rLeEagwrQU
Bella Mehta bella_mehta
4 years 10 months ago
KOA can not only ⬆️ morbidity, it also ⬆️s mortality - long term data from OAI - 5K pts, f/u 9 yrs . Greater KL scores (worse Xrays) - greater mortality!
#ACR21 abst#1028 @RheumNow https://t.co/jREmbEN2Ae
Robert B Chao, MD doctorRBC
4 years 10 months ago
Exercise does not cause objective signs of increased disease activity in PsA
⭐️11 weeks of High Intensity Interval Training in PsA pts did not show worsening changes in MRI SI joint bone marrow edema.
Abs#1362
@RheumNow
#ACRBest
https://t.co/A3aOEy8Wz0 https://t.co/arPvjsbudm
Meral K. El Ramahi, MD MeralElRamahiMD
4 years 10 months ago
Clinical Pearl from Dr. @JKolfenbach
⭐️AAV doesn't typically cause hard palate lesions
Instead, consider:
➡️Cocaine-induced midline destructive lesion
➤try to send human neutrophil elastase ab (+ in cocaine use but not in AAV)
➡️Malignancy (NK T-cell lymphoma)
#ACR21 @RheumNow https://t.co/KIEXgCR23c
David Liew drdavidliew
4 years 10 months ago
TNFi vs tofacitinib drug survival in RA
(based on two Canadian registries, PS adjusted)
This seems to be my refrain this ACR:
'TNF inhibitors: let's not forget, they're quite good'
#ACR21 ABST1217 @RheumNow @Janetbirdope https://t.co/MyFc6do0JL

